UPDATE
Cut in-house R&D and increase outsourcing, says GBI
Cutting in-house R&D staff to outsource more activities cuts will drive the industry forward, according to a new report.
Archives for July 2, 2012
Investments in CMO activities: round up
Outsourcing-Pharma.com presents a round-up of the latest contract manufacturing investments, including new screening services for Imaxio, Encap’s renewed push for its CMO biz, and Pernix’s bid to take over Great Southern Laboratories.
EU defends trials directive but commits to make process faster and more efficient
European laws on clinical trials need to be faster and more efficient but they are not the only reason for the decline in the sector according to EU health and consumer policy commissioner John Dalli.
The quest for more understanding is behind the single use boom: Pall and Thermo Fisher
The implementation of single use technology in the biopharmaceutical fill and finish process has seen a massive uptick recently because of better industry understanding, according to Pall’s Bruce Rawlings.
SFDA draft excipient guidelines place quality burden on pharmas
New Chinese SFDA draft guidelines make pharmaceutical firms more responsible for monitoring excipient quality and assessing suppliers.